Efzofitimod 5 mg/kg ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
84サルコイドーシス1

84. サルコイドーシス


臨床試験数 : 149 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05415137
(ClinicalTrials.gov)
September 15, 20228/6/2022Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisPulmonary SarcoidosisDrug: Efzofitimod 3 mg/kg;Drug: Efzofitimod 5 mg/kg;Drug: PlaceboaTyr Pharma, Inc.Kyorin Pharmaceutical Co.,LtdRecruiting18 Years75 YearsAll264Phase 3United States;Japan;Netherlands;Puerto Rico;Spain